We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Unilever Plc | LSE:ULVR | London | Ordinary Share | GB00B10RZP78 | ORD 3 1/9P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
26.00 | 0.61% | 4,314.00 | 4,314.00 | 4,315.00 | 4,333.00 | 4,281.00 | 4,282.00 | 3,502,925 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Perfume,cosmetic,toilet Prep | 59.6B | 6.49B | 2.5958 | 16.62 | 107.81B |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2022 18:42 | It's starting to rebound a bit, not much. | pander45 | |
18/1/2022 18:38 | Can't imagine why GSK won't sell at such a mad price. Equally I cant see the logic of the huge debt ULVR will take on. Only shareholders will suffer even more than already. Better ULVR is broken up. | cardinal3 | |
18/1/2022 18:24 | PC, FX element in the mix and US markets near session lows. | essentialinvestor | |
18/1/2022 18:17 | Still sinking in NY. | patientcapital | |
18/1/2022 17:58 | Unilever brands are tired Can't they create some new brands "I Can't Believe It's Not Paracetamol" | muffinhead | |
18/1/2022 17:47 | could it be Pfizer blocking it? there is something odd going. | careful | |
18/1/2022 17:41 | careful, exactly. you dont know who is dafter. over 20 times ebitda. rejecting such a price for a single digit margin business. looks like one stone will take out one bird and another ceo. | roguetraderuk | |
18/1/2022 17:38 | why did Glaxo reject it? | careful | |
18/1/2022 17:23 | Do we have a Fred Goodwin type here ? | holts | |
18/1/2022 17:22 | Jope is finished imho. You don't get real howler errors like that too often but when them come there's no coming back. | pander45 | |
18/1/2022 17:09 | monty, you have more chance of winning tonight's Euromillions than an increased offer. Taking on massive debt just as the longer term rates cycle is turning. Market killed the deal stone dead within minutes of Monday's open. Departure of the CEO just a question of when. Jupe can talk until blue in the face, now makes less than 0 difference. Monumental error of judgement and i've seen a few in my time. | essentialinvestor | |
18/1/2022 16:59 | If they up bid another £5 billion to £10 billion, shareprice will tank. But that's what GSK want £60 billion. | montyhedge | |
18/1/2022 16:56 | Richard Buxton has reported by the FT referred to the Unilever top team as..goons running the company.. Bloody hell. Is Terry dumping. | essentialinvestor | |
18/1/2022 16:38 | imo GSK health care will be so loaded with debt that significant risk of share price decline from first day after split - | pugugly | |
18/1/2022 16:22 | Along with his resignation. | pander45 | |
18/1/2022 16:20 | Can't manage what they've got.smacks of desperation to protect their jobs,what a bunch of incompetents. | contrarian joe | |
18/1/2022 16:19 | Management statement later or tomorrow morning. Will say not going to proceed with bid but will grow from bolt on companies to produce product range and growth. Back to normality lol | onehanded | |
18/1/2022 16:19 | Backlash against bid.https://www.ft.c | montyhedge | |
18/1/2022 16:17 | Onehand LOL Ill bet.... :) | stevieweebie2 | |
18/1/2022 16:17 | GSK holding out for £60 billion, I bet Unilever pay up. | montyhedge | |
18/1/2022 16:15 | everyone and his dog in at £35 odd lol. | onehanded |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions